Last quarter (Q2 2022), Santhera Pharmaceuticals Holding's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Santhera Pharmaceuticals Holding's net income was $―. See Santhera Pharmaceuticals Holding’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ ―	$ -1.59M	$ 15.01M	$ 75.38M	$ 31.66M	$ 22.94M
Cost of Revenue	$ ―	$ 3.77M	$ 10.43M	$ 5.45M	$ 4.70M	$ 4.10M
Gross Profit	$ ―	$ -5.36M	$ 4.58M	$ 69.93M	$ 26.95M	$ 18.84M
Operating Expense	$ ―	$ 51.53M	$ 57.65M	$ 80.37M	$ 78.38M	$ 69.29M
Operating Income	$ ―	$ -56.89M	$ -53.08M	$ -10.44M	$ -51.42M	$ -50.45M
Net Non Operating Interest Income Expense	$ ―	$ -6.42M	$ -15.14M	$ -6.07M	$ -4.84M	$ -3.77M
Other Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Pretax Income	$ ―	$ -54.72M	$ -67.46M	$ -18.39M	$ -53.86M	$ -51.27M
Tax Provision	$ ―	$ 809.00K	$ 203.00K	$ 579.00K	$ 322.00K	$ 257.00K
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ -55.53M	$ -67.66M	$ -18.97M	$ -54.19M	$ -51.53M
Basic EPS	$ ―	$ -1.62	$ -5.08	$ -1.73	$ -7.86	$ -8.22
Diluted EPS	$ ―	$ -1.62	$ -5.08	$ -1.73	$ -7.86	$ -8.22
Basic Average Shares	$ ―	$ 34.17M	$ 13.32M	$ 10.99M	$ 6.89M	$ 6.27M
Diluted Average Shares	$ ―	$ 34.17M	$ 13.32M	$ 10.99M	$ 6.89M	$ 6.27M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ 44.00K	$ 16.00K	$ 16.00K	$ 859.00K	$ ―
Total Expenses	$ ―	$ 55.29M	$ 68.08M	$ 85.82M	$ 83.08M	$ 73.40M
Net Income From Continuing And Discontinued Operation	$ ―	$ -55.53M	$ -67.66M	$ -18.97M	$ -54.19M	$ -51.53M
Normalized Income	$ ―	$ -62.89M	$ -68.08M	$ -18.63M	$ -56.31M	$ -53.45M
Interest Expense	$ ―	$ 16.42M	$ 6.89M	$ 6.08M	$ 4.50M	$ 3.84M
EBIT	$ ―	$ -38.29M	$ -60.56M	$ -12.31M	$ -49.36M	$ -47.43M
EBITDA	$ ―	$ -34.57M	$ -53.43M	$ -7.54M	$ -45.62M	$ -44.05M

Currency in USD

Santhera Pharmaceuticals Holding Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing